Aneeka Chatterjee, Sanket Koul

Stories by Aneeka Chatterjee, Sanket Koul

Tylenol row may not hit India's pharma exports

Tylenol row may not hit India's pharma exports

Rediff.com   29 Sep 2025

Amid controversy over USPresident Donald Trump's comments linking the use of Tylenol and other related paracetamol products by pregnant women to autism in children, experts and industry executives say that since India's export of the drug to the US is less, it will hardly affect the country's pharma exports to America.

Drugmakers look to fill Rs 600 cr Novo vacuum

Drugmakers look to fill Rs 600 cr Novo vacuum

Rediff.com   25 Sep 2025

Indian drugmakers Eris Lifesciences, Wockhardt and Lupin are prepping to cash in when Danish company Novo Nordisk bows out of the human insulin pen market by the end of this year and creates an opportunity estimated to be worth Rs 600-800 crore in the domestic market. Some self-use disposable pens are pre-filled with insulin and others can be reused with new cartridges.

SC Verdict Instills Hope For Real Estate Reforms

SC Verdict Instills Hope For Real Estate Reforms

Rediff.com   24 Sep 2025

'The directives to enhance last-mile funding, consider revival funds, and systemic reforms across the sector are expected to revive stalled projects, improve accountability, and accelerate the delivery of affordable and mid-income housing.'

India's legacy liquor brands raise a toast to growth, reinvention

India's legacy liquor brands raise a toast to growth, reinvention

Rediff.com   21 Sep 2025

By 10 am, Rakshit N Jagdale is already deep into the rhythm of the day, which promises to be a carousel of meetings, calls, and strategic decisions. As managing director of Amrut Distilleries, he balances ritual and ambition, tradition and transformation, like many other legacy players in India's alcoholic beverages sector who are staring at a rosy future.

Mankind taps OpenAI to institutionalise AI in ops

Mankind taps OpenAI to institutionalise AI in ops

Rediff.com   18 Sep 2025

Delhi-based pharma major Mankind Pharma on Wednesday announced a collaboration with OpenAI to institutionalise artificial intelligence (AI) across its value chain, making it one of the first few Indian pharmaceutical companies to fully integrate advanced AI into its core operations.

Why Hotels Are Building Branded Residences

Why Hotels Are Building Branded Residences

Rediff.com   29 Aug 2025

'While the concept was introduced globally over four decades ago, branded residences have taken off now in India.'

Senior living market to reach $8 bn by 2030

Senior living market to reach $8 bn by 2030

Rediff.com   28 Aug 2025

With the rise in elderly population and increasing interest around the segment by developers, the senior living industry is poised to reach a market size of $8 billion by 2030 from the current $1.8 to $2 billion, according to a report by Association of Senior Living in India (ASLI) and JLL.

Pharma cos may see short-term price blip: Ind-Ra

Pharma cos may see short-term price blip: Ind-Ra

Rediff.com   27 Aug 2025

Any potential tariffs on pharmaceutical imports into the US are unlikely to impact the credit profiles of Indian firms except for a short-term pricing blip, according to a report by India Ratings and Research (Ind-Ra). The report stated that the US generics market contributes around 35 per cent to the total revenue of the leading Indian pharma firms.

US tariffs threaten to derail India's affordable housing market recovery

US tariffs threaten to derail India's affordable housing market recovery

Rediff.com   12 Aug 2025

The US's recent 50 per cent tariff on Indian exports will have a trickledown effect on India's affordable housing, potentially derailing demand as well as supply in this segment, according to experts. Pointing to worker incomes and jobs in micro, small and medium enterprises (MSMEs), and small and medium enterprises (SMEs) that typically make up majority of the customer base of affordable housing, would take a hit in the near terms due to the tariff change, further crippling India's affordable housing sector, already reeling from the impact of the Covid-19 pandemic.

Indian Pharma Majors Ready With Weight Loss Drugs

Indian Pharma Majors Ready With Weight Loss Drugs

Rediff.com   12 Aug 2025

Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Rediff.com   31 Jul 2025

India's pharmaceuticals and medical devices industries are still hopeful that trade negotiations with the US could cut a fairer deal for both sides, after President Donald Trump announced a 25 per cent tariff rate on India on a social networking platform without divulging the finer details.

Weight-Loss Drug Battle Intensifies

Weight-Loss Drug Battle Intensifies

Rediff.com   22 Jul 2025

'Willingness to try new drugs for obesity management have propelled the growth of this market, which today is almost five times what it was five years ago.'

AdFalciVax Is India's Malaria Vaccine

AdFalciVax Is India's Malaria Vaccine

Rediff.com   21 Jul 2025

'AdFalciVax may offer advantages such as broader protection and a lower risk of immune evasion compared to existing single-stage malaria vaccines.'

Illinois Tech To Open Mumbai Campus Next Year

Illinois Tech To Open Mumbai Campus Next Year

Rediff.com   18 Jul 2025

At the Mumbai campus the institute will offer both UG and graduate degrees, most of its courses will focus on science, technology, engineering and mathematics.

Realty market saw land deals worth Rs 31,000 cr in H1 2025: Anarock

Realty market saw land deals worth Rs 31,000 cr in H1 2025: Anarock

Rediff.com   16 Jul 2025

At least 2,900 acres of land deals, with a market value of Rs 31,000 crore, were transacted in the Indian realty market during the first six months of 2025 (H1 2025), according to a report by real estate analytics firm Anarock. These deals include both outright transactions as well as joint development agreements between realtors and landowners.

Why Students Are Pausing US Plans

Why Students Are Pausing US Plans

Rediff.com   14 Jul 2025

Many students are now looking at opportunities in the UK, Australia, and Singapore due to lower cost of living and less interference from the government.

Wockhardt exits US generics biz, to focus on innovation

Wockhardt exits US generics biz, to focus on innovation

Rediff.com   12 Jul 2025

Mumbai-based pharma major Wockhardt, which is gearing up to launch its promising antibiotic candidate Zaynich soon, on Friday announced a shift in its United States (US) operations. The Indian pharma giant revealed that it has decided to exit the generics pharmaceutical segment in the country.

Now, You Can Study In A UK College... In India

Now, You Can Study In A UK College... In India

Rediff.com   9 Jul 2025

At least six major UK universities have announced plans to set up campuses or liaison offices in India.

Gross office space leasing soars 5% in Q2 of 2025: Cushman & Wakefield

Gross office space leasing soars 5% in Q2 of 2025: Cushman & Wakefield

Rediff.com   8 Jul 2025

Fuelled by the global capability centre (GCC) boom, gross leasing of office space across top eight cities soared 5 per cent to touch 21.4 million square feet (msf) in the second quarter of calendar year 2025, according to Cushman & Wakefield's Q2 India Office Market report.

Siddaramaiah Flags Vaccine-Heart Link

Siddaramaiah Flags Vaccine-Heart Link

Rediff.com   2 Jul 2025

Karnataka Chief Minister Siddaramaiah alleged that the rushed approval and distribution of the COVID-19 vaccine may be a contributing factor to cardiac arrest deaths, citing several international studies that recently suggested a possible link between the vaccines and a rise in heart attacks.